Home » Expert Advice » Medication » Mounjaro » Mounjaro uk price
Mounjaro uk price
Summary
Mounjaro treats obesity and diabetes. NHS eligibility requires specific BMI and conditions. Private costs range £179–£249. Combine with diet, exercise, and support.
To get a prescription for Eli Lilly’s Mounjaro, individuals living with obesity (a BMI between 27 and 30 kg/m² and a weight-related health condition, such as high cholesterol, and high blood pressure) or patients with type-2 diabetes will be eligible. The National Institute for Health and Care Excellence (NICE) has outlined specific eligibility criteria for receiving Mounjaro (active ingredient tirzepatide) via the NHS. This includes individuals who have unsuccessfully tried triple therapy with metformin and two other oral anti-diabetic drugs due to ineffectiveness, intolerance, or contraindications. Additionally, individuals must have a BMI of 35 kg/m2 or more and exhibit specific psychological or medical problems associated with obesity, or have a BMI of less than 35 kg/m2 but face significant occupational implications from insulin therapy or could benefit from weight loss for other obesity-related complications.
You can be prescribed Mounjaro privately through a healthcare provider, the price can change depending on the required maintenance dose. It’s recommended to combine the use of this weight loss medication with a healthy diet, and regular exercise, this is why we have created a complete treatment plan for your weight loss journey; including the weight loss injection pen, access to dieticians, a health coach and a specifically designed weight loss app.
Mounjaro costs for online pharmacies in the UK as of September 2024:
- Boots: £219 for the first four-week supply of 2.5 mg, rising to £249 for the highest dose of 15 mg. (No Aftercare)
- Superdrug: £215 for the first four-week supply of 2.5 mg, rising to £245 for the highest dose of 15 mg (No Aftercare)
- Asda Online Doctor: £179 for the first four-week supply of 2.5 mg, rising to £204 (No Aftercare)
References
Eli Lilly and Company: “Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes.”
Boots Online Doctor : https://onlinedoctor.boots.com/treatments/mounjaro
Asda Online doctor: https://onlinedoctor.asda.com/uk/mounjaro.html
Online doctor superdrug: https://onlinedoctor.superdrug.com/mounjaro.html
Further reading about Mounjaro
- Last Updated: 26/11/2024
- Last Updated: 17/06/2024
- Last Updated: 25/11/2024
- Last Updated: 26/11/2024
- Last Updated: 26/11/2024
- Last Updated: 25/08/2025
Mounjaro Mounjaro is a groundbreaking FDA-approved medication that represents a new frontier in the treatment of type 2